Examining the safety of amiodarone

Author： Santangeli Pasquale   Di Biase Luigi   Burkhardt John David   Bai Rong   Mohanty Prasant   Pump Agnes   Natale Andrea  

Publisher： Informa Healthcare

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.11, Iss.2, 2012-03, pp. : 191-214

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PM101: intravenous amiodarone formulation changes can improve medication safety

By Souney Paul F   Cooper Warren D   Cushing Daniel J  

Expert Opinion on Drug Safety, Vol. 9, Iss. 2, 2010-03 ,pp. : 319-333

Informa Healthcare

Access to resources Recommend Favorite

Examining the safety of PPAR agonists - current trends and future prospects

By Bortolini Michele  

Expert Opinion on Drug Safety, Vol. 12, Iss. 1, 2013-01 ,pp. : 65-79

Informa Healthcare

Access to resources Recommend Favorite

Hyperglobulinemia in Amiodarone-induced Pneumonitis

By Mouallem Meir   Antipov Natalia   Mayan Haim   Sela Ben   Farfel Zvi  

Cardiovascular Drugs and Therapy, Vol. 21, Iss. 1, 2007-02 ,pp. : 63-67

Springer Publishing Company

Access to resources Recommend Favorite

Amiodarone: Hyperthyroidism: case report

By  

Reactions Weekly, Vol. 1, Iss. 1167, 2007-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Amiodarone: Cirrhosis: case report

By  

Reactions Weekly, Vol. 1, Iss. 1085, 2006-01 ,pp. : 6-7

Adis International

Access to resources Recommend Favorite